Soluble endoglin and transforming growth factor‐β1 in women who subsequently developed preeclampsiaPrenatal Diagnosis - Tập 29 Số 5 - Trang 471-476 - 2009
Ji Hyae Lim, Shin Young Kim, So Yeon Park, Moon Hee Lee, Jae Hyug Yang, Moon Young Kim, Jin Hoon Chung, Si Won Lee, Hyun Mee Ryu
AbstractObjectiveThis study aimed to analyze the differences of soluble endoglin (sEng) and transforming growth factor‐beta1 (TGF‐β1) according to preeclamptic complications and to investigate the correlation between these factors and the clinical symptoms of preeclampsia.Method... hiện toàn bộ
First‐trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomesPrenatal Diagnosis - Tập 28 Số 2 - Trang 121-125 - 2008
Nicholas J. Cowans, Kevin Spencer, Hamutal Meiri
AbstractBackgroundIn a previous study, reduced levels of maternal serum placental protein 13 (PP13) in the first trimester have been correlated with adverse pregnancy outcomes. The objective of this study was to compare first‐trimester PP13 levels in control pregnancies with pregnancies resulting in one or more of the following ad...... hiện toàn bộ
Second‐trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre‐eclampsiaPrenatal Diagnosis - Tập 27 Số 3 - Trang 258-263 - 2007
Kevin Spencer, Nicholas J. Cowans, Ilana Chefetz, J. Tal, Ido Kuhnreich, Hamutal Meiri
AbstractObjectiveTo evaluate whether measurement of maternal serum PP13 at 22 to 24 weeks of gestation, alone or in combination with second‐trimester biochemical markers or uterine artery pulsatility measured by Doppler velocimetry, is useful in predicting those women at risk of developing pre‐eclampsia.... hiện toàn bộ
PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsiaPrenatal Diagnosis - Tập 29 Số 13 - Trang 1231-1236 - 2009
Hanako Shimizu, Akihiko Sekizawa, Yuditiya Purwosunu, Masamitsu Nakamura, Antonio Farina, Nicola Rizzo, Takashi Okai
AbstractObjectiveTo assess the PP13 expression in the cellular component of blood in both preeclamptic patients and asymptomatic pregnant women during the early second trimester.MethodsIn the case–control study, peripheral blood samples were obtained from pregnant wome...... hiện toàn bộ
Placental protein 13 as a first trimester screening marker for aneuploidyPrenatal Diagnosis - Tập 29 Số 13 - Trang 1237-1241 - 2009
Maria P. H. Koster, E. J. Wortelboer, Howard Cuckle, P. Stoutenbeek, Gerard H. A. Visser, Peter C. J. I. Schielen
AbstractObjectiveTo determine whether Placental Protein 13 (PP13) could be an additional marker in first trimester screening for aneuploidies.MethodsTo evaluate differences in multiples of the gestation‐specific normal median (MoMs), PP13 concentrations were measured i...... hiện toàn bộ
Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defectsPrenatal Diagnosis - Tập 28 Số 6 - Trang 485-493 - 2008
Raf Brouns, N. T. C. Ursem, Jan Lindemans, Wim C.J. Hop, Saskia M.F. Pluijm, Eric A.P. Steegers, Régine P.M. Steegers‐Theunissen
AbstractObjectiveTo investigate the associations between biomarkers and genetic variants involved in homocysteine metabolism and the risk of complex birth defects.MethodsTotal homocysteine (tHcy), folate, cobalamin, apo‐transcobalamin (apo‐TC) and apo‐haptocorrin (apo‐...... hiện toàn bộ
Funipuncture for fetocide in late termination of pregnancyPrenatal Diagnosis - Tập 22 Số 5 - Trang 354-356 - 2002
M.V. Senat, C. Fischer, Y. Ville
AbstractThe most widely used method for fetocide in late termination of pregnancy for fetal abnormalities (TOPFA) consists of injecting of potassium chloride (KCl) into the fetal heart and is likely to be painful after 22 weeks of gestation. We studied ten consecutive women undergoing TOPFA between 22 and 38 weeks. This technique for fetocide consisted of a single ...... hiện toàn bộ